The move dovetails with other steps that Hywin has taken in recent months.

Hywin Holdings is teaming up with Switzerland’s Leonteq Securities and Arta TechFin, a Hong Kong-listed fintech, to launch a global healthcare structured product.

The product, a principal-protected note, is linked to the FactSet Hywin Global Health Care Index™ (FHGHC).

Arta has been engaged as a licensed strategic distribution partner in Hong Kong and in the rest of Asia-Pacific region via its partnership network. The product will be introduced to family offices and asset managers.

The product is driven by Hywin’s healthcare insights and calculated using FactSet’s proprietary datasets. It tracks more than 40 stocks selected from 19 stock exchanges across 36 sub-sectors of healthcare, with constituent companies such as GSK PLC, BAYER AG, Thermo Fisher, Johnson & Johnson, Pfizer, Daiichi Sankyo, HCA Healthcare, and other global healthcare firms. As of 20 March 2023, the index had achieved total returns of more than 66 per cent in the previous three years, beating various global healthcare thematic indices compiled by S&P, MSCI, Dow Jones, and NASDAQ, Hywin said in a statement. 

“Asian clients and investors increasingly favour healthcare as a highly investable mega-trend. This structured note is the first commercialisation of the FactSet Hywin index, and combines an attractive theme with principal protection features to present a compelling building block for clients’ portfolios,” Nick Xiao, chief executive of Hywin International, the Hong Kong subsidiary of Hywin Holdings, said. 

The move dovetails with other steps that Hywin has taken in recent months. In August last year it took a controlling stake in Life Infinity as part of a push into the country’s health management sector. The Chinese business launched the FactSet Hywin Global Health Care Index last year.